UBS Oncology Impact Fund - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $99,294.46 +1.19%
Ethereum $3,311.35 -1.58%
BNB $628.65 +0.88%
Optimism $2.15 +2.89%
Arbitrum $0.79 +0.15%
Solana $257.16 +1.18%
Polygon $0.48 +7.93%
Cosmos $7.36 +15.22%
Avalanche $41.41 +15.51%

Bitcoin $99,294.46 +1.19%
Ethereum $3,311.35 -1.58%
BNB $628.65 +0.88%
Optimism $2.15 +2.89%
Arbitrum $0.79 +0.15%
Solana $257.16 +1.18%
Polygon $0.48 +7.93%
Cosmos $7.36 +15.22%
Avalanche $41.41 +15.51%

UBS Oncology Impact Fund

investment firm

Summary
Investments
Exits

About

UBS Oncology Impact Fund

Highlights

Lead Investments

Details

Operating Status: Active

Investments

Number of Investments

Number of Lead Investments

5

1

UBS Oncology Impact Fund has made 5 investments. Their most recent investment was on Sep 4, 2019, when Repare Therapeutics raised $82.50M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Sep 4, 2019 Repare Therapeutics	Series B	$82.50M	Biotechnology	—
Aug 21, 2019 Oncorus	Series B	$79.50M	Biotechnology	—
May 13, 2019 ElevateBio	Series A	$150M	Biotechnology	Yes
Oct 3, 2017 Cullinan Oncology	Series A	$150M	Biopharma	—
Jun 22, 2017 Repare Therapeutics	Series A	$68M	Biotechnology	—

Exits

UBS Oncology Impact Fund has had 3 exits. UBS Oncology Impact Fund most notable exits include Cullinan Oncology , Oncorus

Date	Company Name	Exit Type	Industry
Jan 7, 2021	Cullinan Oncology	IPO	Biopharma	Detail
Oct 1, 2020	Oncorus	IPO	Biotechnology	Detail
Jun 18, 2020	Repare Therapeutics	IPO	Biotechnology	Detail